CR was inevitable at some point. It's not good news or bad...

CR was inevitable at some point. It's not good news or bad news... completely neutral.

'What they do' with the money raised will determine whether this was a good or a bad move, but it IS good to know funding is secured through to FDA approval.

Some 'fresh talent' on board - well I've heard that before... again, lets judge this on 'what they do'.

I expect SP to sit around 11 to 14 c for a while, but if you're not selling, and beleive in the product and AVH's ability to take it to market, then it could drop to 5c and wouldn't make a difference. AVH is a high risk/high reward stock, and LONG term I beleive prices will definately go higher than they are now - even in the run up to FDA. With good FDA results and the media swarm that will inevitably follow, 30c will be cheap.

So if you're prepared to put your money in and forget about it for a long time, I beleive you will be rewarded. If you are a short term trader, then I don't think this is the stock for you.